Cognitive dysfunction in MS patients is known to be associated with physical disability and impaired quality of life, but is often overlooked in clinical practice. To assess cognitive function in MS patients, several tests have been developed. However, performing these tests is challenging in routine clinical settings because of time constraints and unavailability of trained technicians.
The PST is a tablet/computer application designed to evaluate cognitive function in patients with MS. It is a modified form of the Symbol Digit Modality Test (SDMT) and its close performance correlates with the original SDMT. One advantage of the PST is that it can be performed by patients themselves in a relatively short period. Therefore, the test is a reliable and convenient method for assessing cognitive function in MS patients in clinical settings.
Dr Yusei Miyazaki (NHO Hokkaido Medical Center, Japan) and colleagues evaluated the usefulness of the PST by assessing the relationship between performance and physiological disability domains of this test and brain volume, depression, fatigue, and quality of life in MS patients. Included were 47 patients with a mean age of 40.7; 68% were female; mean disease duration was 10.1 years; and median Expended Disability Status Scale (EDSS) score 2.0.
The mean PST score was 53.6, and this correlated negatively with EDSS, Beck Depression Inventory (BDI)-II, and Fatigue Severity Scale (FSS); while correlating positively with total brain volume, cortical grey matter volume, and Functional Assessment of MS (FAMS) score. The authors suggested that the PST is a reliable and convenient tool to evaluate cognitive function in MS patients.
- Miyazaki Y, et al. Clinical utility of the Processing Speed Test in patients with multiple sclerosis. ECF 28th Annual Meeting. Abstract 76.
Posted on
Previous Article
« Tackling unmet MS-related cognitive challenges Next Article
Progressive aerobic exercise improves fatigue »
« Tackling unmet MS-related cognitive challenges Next Article
Progressive aerobic exercise improves fatigue »
Table of Contents: ECF 2020
Featured articles
ECF Round-Up Articles
No association between Ig levels and infection in ofatumumab-treated patients with relapsing MS
Defining phenotypes of MS-related cognitive impairment
First long-term efficacy data of a BTK inhibitor
Novel disease-specific scale confirms huge impact of fatigue
Progressive aerobic exercise improves fatigue
Reliable and convenient method to assess cognitive function in MS patients
Tackling unmet MS-related cognitive challenges
Real-world efficacy of ocrelizumab in MS patients
Similar demographics, clinical characteristics, and treatment patterns in German claims study
Decreased EDSS after plasma exchange in NMOSD
No support for IVIG as treatment of acute attacks in NMOSD
Related Articles
December 16, 2020
Real-world efficacy of ocrelizumab in MS patients
December 16, 2020
Tackling unmet MS-related cognitive challenges
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com